PT825861E - Tripicolinato cromico em doses elevadas para o tratamento de diabetes de tipo ii - Google Patents

Tripicolinato cromico em doses elevadas para o tratamento de diabetes de tipo ii

Info

Publication number
PT825861E
PT825861E PT96915595T PT96915595T PT825861E PT 825861 E PT825861 E PT 825861E PT 96915595 T PT96915595 T PT 96915595T PT 96915595 T PT96915595 T PT 96915595T PT 825861 E PT825861 E PT 825861E
Authority
PT
Portugal
Prior art keywords
tripycolinate
diabetes
chromium
treatment
type
Prior art date
Application number
PT96915595T
Other languages
English (en)
Inventor
Mark F Mccarty
Original Assignee
Nutrition 21
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition 21 filed Critical Nutrition 21
Publication of PT825861E publication Critical patent/PT825861E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
PT96915595T 1995-05-12 1996-05-08 Tripicolinato cromico em doses elevadas para o tratamento de diabetes de tipo ii PT825861E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/440,362 US6329361B1 (en) 1995-05-12 1995-05-12 High-dose chromic picolinate treatment of type II diabetes

Publications (1)

Publication Number Publication Date
PT825861E true PT825861E (pt) 2003-03-31

Family

ID=23748461

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96915595T PT825861E (pt) 1995-05-12 1996-05-08 Tripicolinato cromico em doses elevadas para o tratamento de diabetes de tipo ii

Country Status (15)

Country Link
US (1) US6329361B1 (pt)
EP (1) EP0825861B1 (pt)
JP (1) JP3699124B2 (pt)
AR (1) AR004486A1 (pt)
AT (1) ATE227127T1 (pt)
AU (1) AU5733796A (pt)
BR (1) BR9608835A (pt)
DE (1) DE69624699T2 (pt)
DK (1) DK0825861T3 (pt)
ES (1) ES2183952T3 (pt)
IL (1) IL118222A (pt)
PT (1) PT825861E (pt)
RU (1) RU2195934C2 (pt)
WO (1) WO1996035421A1 (pt)
ZA (1) ZA963735B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
JP2001513506A (ja) * 1997-08-08 2001-09-04 ニュートリション ２１ タイプｉｉ糖尿病のクロム／ビオチン治療
US5789401A (en) * 1997-08-08 1998-08-04 Nutrition 21 High-dose chromium/biotin treatment of type II diabetes
EP0925790A1 (en) * 1997-12-17 1999-06-30 Kartar Dr. Lalvani Vitamin and mineral combinations for the treatment of syndrome X and non-insulin dependent diabetes (NIDDM)
US5932258A (en) * 1998-04-06 1999-08-03 The Iams Company Composition and process for improving glucose metabolism in companion animals
US6143301A (en) 1998-08-28 2000-11-07 Ambi Inc. Chromium picolinate compositions and uses thereof
US5948772A (en) 1998-08-28 1999-09-07 Ambi Inc. Chromium picolinate compositions and uses thereof
US5905075A (en) * 1998-08-28 1999-05-18 Ambi Inc. Chromium nicotinate compositions and uses thereof
US6376549B1 (en) 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
WO2000015211A2 (en) 1998-09-17 2000-03-23 Akesis Pharmaceuticals, Inc. Compositions of chromium or vanadium with antidiabetics for glucose metabolism disorders
JP2004509143A (ja) 2000-09-21 2004-03-25 ニュートリション　２１、インコーポレイテッド クロム錯体、共役脂肪酸及び／又は共役脂肪アルコールによる糖尿病の治療、体脂肪減少、インシュリン感受性の改善、高血糖症軽減及び高コレステロール血症軽減の方法及び組成物
WO2003090671A2 (en) * 2002-04-23 2003-11-06 Nutrition 21, Inc. Chromium compositions and methods for using the same for inhibiting drug-induced insulin resistance
DE60333628D1 (de) * 2002-05-14 2010-09-16 Nipro Corp Medikament zur prävention und behandlung von familiärer amyloid polyneuropathie
US6831077B2 (en) * 2002-07-25 2004-12-14 Comprehensive Neuroscience, Inc. Augmentation of atypical antipsychotic agent pharmacotherapy with chromium supplementation
US20050019435A1 (en) * 2003-07-21 2005-01-27 Jeffrey Young Method of treating non-insulin dependent diabetes mellitus and related complications
US20050085454A1 (en) * 2003-10-16 2005-04-21 Natreon Inc. Phenolic antioxidant-chromium complexes for treatment or prevention of type 2 diabetes or glucose intolerance
CA2676977C (en) * 2007-01-31 2016-10-04 Nutrition 21, Inc. Use of chromium histidinate for treatment of cardiometabolic disorders
EP2134351B1 (en) 2007-03-13 2016-04-27 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
PL2448412T3 (pl) 2009-07-01 2019-11-29 Jds Therapeutics Llc Kompleksy chromu jako środki podnoszące poziom transporterów glukozy w mózgu
WO2012119007A1 (en) 2011-03-01 2012-09-07 N21 Acquisition Holding, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
US11547125B2 (en) 2015-02-13 2023-01-10 Mars, Incorporated Pet food feeding system
CN109069532A (zh) 2016-02-11 2018-12-21 营养21有限责任公司 含铬组合物用于改善健康和健身
US10820617B1 (en) 2018-03-29 2020-11-03 Government Of The United States, As Represented By The Secretary Of The Air Force All inclusive electrolytes, vitamins, and protein powder training supplement

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315927A (en) * 1980-08-08 1982-02-16 The United States Of America As Represented By The Secretary Of Agriculture Dietary supplementation with essential metal picolinates
US5087623A (en) * 1988-05-31 1992-02-11 Nitrition 21 Chromic picolinate treatment
US5164384A (en) 1991-06-19 1992-11-17 Metagenics, Inc. Anabolic mineral formula

Also Published As

Publication number Publication date
EP0825861A1 (en) 1998-03-04
WO1996035421A1 (en) 1996-11-14
IL118222A0 (en) 1996-09-12
DE69624699D1 (de) 2002-12-12
DE69624699T2 (de) 2003-03-20
JPH11504941A (ja) 1999-05-11
AR004486A1 (es) 1998-12-16
ATE227127T1 (de) 2002-11-15
DK0825861T3 (da) 2003-03-03
JP3699124B2 (ja) 2005-09-28
IL118222A (en) 2000-06-01
AU5733796A (en) 1996-11-29
BR9608835A (pt) 1999-12-07
ZA963735B (en) 1997-01-09
ES2183952T3 (es) 2003-04-01
EP0825861B1 (en) 2002-11-06
RU2195934C2 (ru) 2003-01-10
MX9708628A (es) 1998-06-28
US6329361B1 (en) 2001-12-11

Similar Documents

Publication Publication Date Title
PT825861E (pt) Tripicolinato cromico em doses elevadas para o tratamento de diabetes de tipo ii
NO970800L (no) Spiroazabicykliske forbindelser som er nyttige i terapi
PT861666E (pt) Composicao farmaceutica para utilizacao no tratamento da diabetes
PT781136E (pt) Compostos e processos para o tratamento do cancro
BR9604872A (pt) Composição para tratamento de cabelo
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
DE59406123D1 (de) Haarbehandlungsmittel
DE59407363D1 (de) Wegwerfwindel
DE69425088D1 (de) Wegwerfwindel
DE69410520D1 (de) Behandlungsbehälter
PT1033990E (pt) 21-hidroxi-6,19-oxidoprogesterona (21oh-6op) e a sua utilizacao como medicamento para tratar o excesso de glucocorticoides
PT1017408E (pt) Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
PT752870E (pt) Utilizacao de mycobacterium para o tratamento de tumores
KR950013377U (ko) 쑥뜸구
PT970080E (pt) Derivados de imino-aza-antraciclinona para o tartamento de amiloidoses
DE59510194D1 (de) Dose
FR2713479B1 (fr) Bassin médical.
KR950005692U (ko) 뜸 치료용 발열기
KR950003749U (ko) 폐수 처리기
KR950010930U (ko) 쑥뜸구
ES1023597Y (es) Vendaje terapeutico perfeccionado.
BR9304388A (pt) Composição terapêutica de uso nasal
BR9302334A (pt) Urovarginal para pacientes
SE9300795D0 (sv) Ny princip foer smaertbehandling
KR950032386U (ko) 약재를 내장한 샤워콕